$6.540
+0.164 (+2.51%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Bolt Biotherapeutics, Inc. (BOLT) Moving Averages Convergence Divergence (MACD) indicator is 0.71, suggesting BOLT is Strong buy.
Bolt Biotherapeutics, Inc. (BOLT) 20-Day simple moving average is 5.42, while Bolt Biotherapeutics, Inc. (BOLT) share price is $—, making it Buy.
Bolt Biotherapeutics, Inc. (BOLT) 60-Day simple moving average is 4.25, while Bolt Biotherapeutics, Inc. (BOLT) share price is $—, making it Buy.
Technical Analysis for BOLT
AI Technical BOLTAs of 2026-11-07, the technical board for Bolt Biotherapeutics, Inc. (BOLT) reads strong buy: 9 indicators are flashing buy, 0 are indicating sell, and 4 are neutral. Price at $6.54 sits above every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 68.773, MACD stands at 0.713 (Buy), Stochastic %K stands at 66.034, Stochastic %D stands at 66.333 and CCI stands at 60.948.
BOLT trades above the 60-day SMA (4.25) and above the 200-day SMA (4.51). Immediate resistance sits at Classic R1 6.86, then R2 7.25. Support sits at Classic S1 6.09, then S2 5.70.
Bolt Biotherapeutics, Inc. (BOLT) Support & Resistance Level
Bolt Biotherapeutics, Inc. (BOLT) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 68.773 |
| STOCHk_14_3_3 | 66.034 |
| STOCHd_14_3_3 | 66.333 |
| CCI_20 | 60.948 |
| AO_5_34 | 1.687 |
| MOM_10 | 0.270 |
| MACD_12_26_9 | 0.713 |
Bolt Biotherapeutics, Inc. (BOLT) Relative Strength Index (RSI_14) is 68.773, creating a Neutral signal.
Bolt Biotherapeutics, Inc. (BOLT) Stochastic %K is 66.034, creating a Neutral signal.
Bolt Biotherapeutics, Inc. (BOLT) Stochastic %D is 66.333, creating a Neutral signal.
Bolt Biotherapeutics, Inc. (BOLT) CCI_20 is 60.948, creating a Neutral signal.
Bolt Biotherapeutics, Inc. (BOLT) Awesome Oscillator (AO) is 1.687, creating a Buy signal.
Bolt Biotherapeutics, Inc. (BOLT) Momentum (MOM) is 0.270, creating a Buy signal.
Bolt Biotherapeutics, Inc. (BOLT) Moving Average Convergence Divergence (MACD) is 0.713, creating a Buy signal.
Bolt Biotherapeutics, Inc. (BOLT) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 6.454 | Buy |
| MA_10 | 6.476 | Buy |
| MA_20 | 5.423 | Buy |
| MA_60 | 4.254 | Buy |
| MA_200 | 4.508 | Buy |
| MA_250 | 4.690 | Buy |
Bolt Biotherapeutics, Inc. (BOLT) 5-Day simple moving average is 6.454, while Bolt Biotherapeutics, Inc. (BOLT) share price is $, making it a Buy.
Bolt Biotherapeutics, Inc. (BOLT) 10-Day simple moving average is 6.476, while Bolt Biotherapeutics, Inc. (BOLT) share price is $, making it a Buy.
Bolt Biotherapeutics, Inc. (BOLT) 20-Day simple moving average is 5.423, while Bolt Biotherapeutics, Inc. (BOLT) share price is $, making it a Buy.
Bolt Biotherapeutics, Inc. (BOLT) 60-Day simple moving average is 4.254, while Bolt Biotherapeutics, Inc. (BOLT) share price is $, making it a Buy.
Bolt Biotherapeutics, Inc. (BOLT) 200-Day simple moving average is 4.508, while Bolt Biotherapeutics, Inc. (BOLT) share price is $, making it a Buy.
Bolt Biotherapeutics, Inc. (BOLT) 250-Day simple moving average is 4.690, while Bolt Biotherapeutics, Inc. (BOLT) share price is $, making it a Buy.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.